AU2001263943A1 - Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient - Google Patents

Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient

Info

Publication number
AU2001263943A1
AU2001263943A1 AU2001263943A AU6394301A AU2001263943A1 AU 2001263943 A1 AU2001263943 A1 AU 2001263943A1 AU 2001263943 A AU2001263943 A AU 2001263943A AU 6394301 A AU6394301 A AU 6394301A AU 2001263943 A1 AU2001263943 A1 AU 2001263943A1
Authority
AU
Australia
Prior art keywords
oxoaldehydes
serum
patient
blood
whole blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001263943A
Inventor
Wolfgang Kleibohmer
Uta Schulze-Pellengahr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut fuer Chemo und Biosensorik Muenster eV ICB
Original Assignee
Institut fuer Chemo und Biosensorik Muenster eV ICB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut fuer Chemo und Biosensorik Muenster eV ICB filed Critical Institut fuer Chemo und Biosensorik Muenster eV ICB
Publication of AU2001263943A1 publication Critical patent/AU2001263943A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/082—Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography

Abstract

A method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient. A respiratory air sample is analyzed for the presence of at least one alpha-oxoaldehyde, and the presence of alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of the patient is determined from the results of the analysis.
AU2001263943A 2000-06-09 2001-05-29 Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient Abandoned AU2001263943A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10028548 2000-06-09
DE10028548A DE10028548C1 (en) 2000-06-09 2000-06-09 Method for the detection of alpha-oxoaldehydes in whole blood, blood plasma and / or serum of a patient
PCT/EP2001/006101 WO2001094942A1 (en) 2000-06-09 2001-05-29 Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient

Publications (1)

Publication Number Publication Date
AU2001263943A1 true AU2001263943A1 (en) 2001-12-17

Family

ID=7645215

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001263943A Abandoned AU2001263943A1 (en) 2000-06-09 2001-05-29 Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient

Country Status (9)

Country Link
US (1) US6884223B2 (en)
EP (1) EP1287356B1 (en)
JP (1) JP2004501366A (en)
KR (1) KR20030014691A (en)
AT (1) ATE262179T1 (en)
AU (1) AU2001263943A1 (en)
DE (2) DE10028548C1 (en)
RU (1) RU2002132381A (en)
WO (1) WO2001094942A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10134568C2 (en) * 2001-07-16 2003-07-24 Inst Chemo Biosensorik Method for the quantitative determination of alpha-oxoaldehyde
DE10202893A1 (en) * 2002-01-25 2003-08-07 Inst Chemo Biosensorik Method for the specific determination of methylglyoxal in liquid and / or gaseous samples
FR2888128B1 (en) * 2005-07-11 2007-10-12 Maintenance Securite Installat METHOD FOR CONTROLLING THE LEAKAGE RATE OF ACTIVE COAL FILTERS
AT14763U1 (en) * 2008-10-16 2016-05-15 Darwin Gmbh Set and method for obtaining a breathing air sample
US10445846B2 (en) 2011-04-14 2019-10-15 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US10853819B2 (en) 2011-04-14 2020-12-01 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US9770189B2 (en) 2011-08-16 2017-09-26 Elwha Llc Systematic distillation of status data relating to regimen compliance
RU2475733C1 (en) * 2011-08-22 2013-02-20 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Method of determining content of troxerutin, dexpanthenol, benzocaine and methyl parahydroxybenzoate in medical drug by hplc
RU2476873C1 (en) * 2011-08-22 2013-02-27 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Method of determining content of oestrogen and dexpanthenol in two-component medical drug by hplc
RU2517761C1 (en) * 2012-11-08 2014-05-27 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Method of determining content of hydroxymethyl quinoxyline dioxide and impurities thereof by hplc
CN111398460A (en) * 2020-04-02 2020-07-10 必睿思(杭州)科技有限公司 Method for detecting content of aldehydes and ketones in human exhaled air
CN112255354B (en) * 2020-09-11 2021-09-10 广州医科大学附属第一医院 Characteristic substance for diagnosing Marneffei panuliasis and screening method and application thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792272A (en) * 1973-01-12 1974-02-12 Omicron Syst Corp Breath test device for organic components, including alcohol
DD219287A1 (en) * 1983-11-02 1985-02-27 Adw Ddr MEASURING DEVICE FOR CONTROLLING BLOOD SUGAR
US5174959A (en) * 1986-12-22 1992-12-29 Abbott Laboratories Breath component monitoring device
US5370114A (en) * 1992-03-12 1994-12-06 Wong; Jacob Y. Non-invasive blood chemistry measurement by stimulated infrared relaxation emission
JP2727289B2 (en) * 1993-09-29 1998-03-11 呉羽化学工業株式会社 3-deoxyglucosone derivative and its quantification method
US5494562A (en) * 1994-06-27 1996-02-27 Ciba Corning Diagnostics Corp. Electrochemical sensors
GB9704676D0 (en) * 1997-03-06 1997-04-23 Aromascan Plc Condition indicator
WO1998057145A1 (en) * 1997-06-10 1998-12-17 Quadrivium, L.L.C. System and method for detection of a biological condition
GB9711994D0 (en) 1997-06-11 1997-08-06 Glaxo Group Ltd Chemical compounds
DE1075286T1 (en) * 1998-05-06 2002-05-23 Isotechnika,Inc. 13C-glucose breath test to diagnose diabetes indications and monitor glycemic control
WO1999066304A1 (en) * 1998-06-19 1999-12-23 California Institute Of Technology Trace level detection of analytes using artificial olfactometry
DE10202893A1 (en) * 2002-01-25 2003-08-07 Inst Chemo Biosensorik Method for the specific determination of methylglyoxal in liquid and / or gaseous samples

Also Published As

Publication number Publication date
EP1287356A1 (en) 2003-03-05
US20030176805A1 (en) 2003-09-18
DE10028548C1 (en) 2001-08-30
ATE262179T1 (en) 2004-04-15
RU2002132381A (en) 2004-04-27
WO2001094942A1 (en) 2001-12-13
JP2004501366A (en) 2004-01-15
DE50101715D1 (en) 2004-04-22
EP1287356B1 (en) 2004-03-17
US6884223B2 (en) 2005-04-26
KR20030014691A (en) 2003-02-19

Similar Documents

Publication Publication Date Title
WO2002084266A3 (en) Biological measurement system
AU2002367597A1 (en) System, method and apparatus for the rapid detection and analysis of airborne biological agents
WO2003060653A3 (en) Method and/or system for analyzing biological samples using a computer system
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
AU2001278452A1 (en) Method for the detection of influenza a/b viruses
AU5332898A (en) Detection of conditions by analysis of gases or vapours
AU2001263943A1 (en) Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient
WO2004040257A3 (en) Nox monitor using differential mobility spectrometry
TW200512457A (en) Method of diagnosing SARS corona virus infection
WO2003106964A3 (en) High throughput methods and devices for assaying analytes in a fluid sample
ATE327511T1 (en) PROTEOME ANALYSIS METHODS
AU4040097A (en) Signal amplification method
WO2002008461A3 (en) A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS
WO2004031403A8 (en) Method for detecting and counting micro-organisms in a sample
WO2002059379A3 (en) Methods for detecting, grading or monitoring an $i(h. pylori) infection
AU3772495A (en) Method for specifically detecting a coagulation factor V which has an increased stability toward activated protein C in the activated state
AU2003289853A1 (en) Methods, device and instrument for detection of analytes
WO2002059599A3 (en) System and method for in vitro analysis of therapeutic agents
WO2004109286A3 (en) Methods for detecting and treating cancer using podocalyxin and/or endoglycan
WO2004071273A3 (en) Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
GR1004071B (en) Simultaneous analysis of blood samples and evaluation of blood content (hemoglobin)
WO2001042503A3 (en) Apparatus and methods for drug screening based on nucleic acid analysis
WO2006051551A3 (en) Device and method for analysis of a metabolic malady
HUP0401953A2 (en) Biotin derivatives
ATE182987T1 (en) DETECTION METHOD AND DEVICE THEREFOR